Back to Search Start Over

Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study

Authors :
Zhu, Zhaohua
Huang, Jing-Yang
Ruan, Guangfeng
Cao, Peihua
Chen, Shibo
Zhang, Yan
Han, Weiyu
Chen, Tianyu
Cai, Xiaoyan
Liu, Jia
Tang, Yujin
Yu, Na
Wang, Qian
Hunter, David J.
Wei, James Cheng-Chung
Ding, Changhai
Source :
CMAJ: Canadian Medical Association Journal. December 19, 2022, Vol. 194 Issue 49, pE1672, 10 p.
Publication Year :
2022

Abstract

Background: It is uncertain whether metformin use is associated with reduced risk of joint replacement in patients with type 2 diabetes mellitus. We aimed to establish whether metformin use was associated with a reduced risk of total knee replacement (TKR) or total hip replacement (THR) among these patients. Methods: We selected patients with type 2 diabetes mellitus that was diagnosed between 2000 and 2012 from the Taiwan National Health Insurance Research Database. We used prescription time-distribution matching and propensity-score matching to balance potential confounders between metformin users and nonusers. We assessed the risks of TKR or THR using Cox proportional hazards regression. Results: We included 20 347 participants who were not treated with metformin and 20 347 who were treated with metformin, for a total of 40694 participants (mean age 63 yr, standard deviation 11 yr; 49.8% were women) after prescription time-distribution matching. Compared with participants who did not use metformin, those who used metformin had lower risks of TKR or THR (adjusted hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.60-0.81 for TKR or THR; adjusted HR 0.71, 95% CI 0.61-0.84 for TKR; adjusted HR 0.61, 95% CI 0.41-0.92 for THR) after adjustment for covariates. Propensity-score matching analyses (10163 participants not treated with metformin v. 10163 treated with metformin) and sensitivity analyses using inverse probability of treatment weighting and competing risk regression showed similar results. Interpretation: Metformin use in patients with type 2 diabetes mellitus was associated with a significantly reduced risk of total joint replacement. Randomized controlled clinical trials in patients with osteoarthritis are warranted to determine whether metformin is effective in decreasing the need for joint replacement.<br />Osteoarthritis (OA) is a chronic joint disorder and a leading cause of pain, loss of function and disability among older adults. (1) It is a heterogeneous disease characterized by multifactorial [...]

Details

Language :
English
ISSN :
08203946
Volume :
194
Issue :
49
Database :
Gale General OneFile
Journal :
CMAJ: Canadian Medical Association Journal
Publication Type :
Periodical
Accession number :
edsgcl.730074699
Full Text :
https://doi.org/10.1503/cmaj.220952